Polmed calls for reallocation of NFZ’s windfall proceeds
2010-07-07
The National Chamber of the Medical Products Industry (Polmed) has appealed to health and finance ministers to reject the National Health Fund (NFZ)’s proposal for amending its 2010 budget, claiming that it reinforces an existing pattern of disproportionately low NFZ spending on orthopaedic and other auxiliary equipment compared with drug reimbursement.
The Fund forecasts that it will have an extra PLN 2bn (€487m) to spend this year, owing to higher-than-expected receipts from mandatory healthcare contributions. But the Chamber disputes the proposed allocation of the extra funds, and is pushing for a bigger increase in spending on orthopaedic equipment.
In an open letter, Witold Wlodarczyk, director general of Polmed, notes that the revised budget proposal provides for a 11.83% rise in reimbursement spending (i.e. by PLN 899m or €219m), but only a 2.17% rise in spending on orthopaedic and other auxiliary medical equipment (by just PLN 12.3m or €3m). According to Wlodarczyk, this is contrary to earlier declarations by ministry officials.
1 year subscription to internet service providing market news, analyses and analytical articles
Pharma Poland Online provides news, articles and market data on the pharmaceutical market in Poland, from manufacturers and distributors to medical devices and research developments. We have been covering this sector in detail since 2004 and an archive is available. Approximately 120 industry updates are added each month. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
1 year subscription: (52 issues of weekly news and 12 issues of monthly analysis)
Pharma Poland News is an English language information service covering the pharmaceutical sector in Poland, and broadening its horizons to other Central and Eastern European countries. The service includes weekly and monthly newsletters, both delivered by email in pdf format.
Date: Periodic publication
Language: English
Delivery: PDF file
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
No. pages: n/a
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.